The history of the erectile dysfunction drug presents a complex picture for investors. While the initial release generated substantial profits, the lapse of its intellectual property protection opened the floodgates to https://gogogobookmarks.com/story21666126/the-copyright-and-the-pharmaceutical-industry-a-precarious-investment